Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
Citations Over TimeTop 1% of 2015 papers
Abstract
Papillary renal cell carcinoma (pRCC) is an important subtype of kidney cancer with a problematic pathological classification and highly variable clinical behaviour. Here we sequence the genomes or exomes of 31 pRCCs, and in four tumours, multi-region sequencing is undertaken. We identify BAP1, SETD2, ARID2 and Nrf2 pathway genes (KEAP1, NHE2L2 and CUL3) as probable drivers, together with at least eight other possible drivers. However, only ~10% of tumours harbour detectable pathogenic changes in any one driver gene, and where present, the mutations are often predicted to be present within cancer sub-clones. We specifically detect parallel evolution of multiple SETD2 mutations within different sub-regions of the same tumour. By contrast, large copy number gains of chromosomes 7, 12, 16 and 17 are usually early, monoclonal changes in pRCC evolution. The predominance of large copy number variants as the major drivers for pRCC highlights an unusual mode of tumorigenesis that may challenge precision medicine approaches.
Related Papers
- → Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma(2023)70 cited
- → Exome copy number variant detection, analysis, and classification in a large cohort of families with undiagnosed rare genetic disease(2024)18 cited
- → An Update on the Treatment of Papillary Renal Cell Carcinoma(2023)17 cited
- → Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma(2021)10 cited
- → Cross-validation and cross-study validation of kidney cancer with machine learning and whole exome sequences from the National Cancer Institute(2018)5 cited